Predict your next investment

HEALTHCARE | Pharmaceuticals / Drugs

See what CB Insights has to offer


Seed | Alive

Total Raised


Last Raised

$2.25M | 16 yrs ago

About Glykoz

Developer of anti-infective pharmaceuticals. The company aims to treat disorders such as chronic degenerative diseases, cancer, infections, and immune dysfunction. It has a strategic alliance with Griffith University’s Institute for Glycomics and Monash University’s Department of Microbiology.

Glykoz Headquarter Location

15 Chopin Court

Nerang, 4211,


61 7 5596 7714

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.